Dealwatch: Baker & McKenzie and Ropes & Gray lead on Merck’s $8.4bn superbug takeover Legal Business9 December 2014Corporate and M&ADeal watchUS firms One of the world’s biggest pharma groups, New Jersey-based Merck, instructed an all-female partner team from Baker & McKenzie to help it execute its $8.4bn takeover of Cubist Pharmaceuticals.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryRevolving Doors: Willkie hires from Kirkland in Germany, while Slaughters London partner surfaces at SimmonsRevolving Doors: Latham swipes German transactions team from Freshfields as Ropes rebuilds in private equityMeal Deal Maker: LB lunches with top City partners – Ropes & Gray’s Libby Todd‘There are winners and losers’ – Hogan Lovells and Cadwalader’s leaders on why their merger makes senseA merger or a takeover? Winston Taylor by the numbers‘History in the making’ – Hogan Lovells set for record $3.6bn merger with Cadwalader‘There’s a lot of money in Chicago’ – the city’s top lawyers on what’s driving business in the MidwestLegal 500 US: Latham tops the charts in new US rankingsDealwatch: Global 100 advisers take centre stage on BlackRock-GIP $12.5bn mega deal